Velarion · Company Intelligence
Compensation Brief
Fiscal year 2024 · Filings through 2026-01-09

Anavex Life Sciences (AVXL)

Fiscal year 2024 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$2,783,700
Christopher Missling total, FY2024
CEO pay percentile vs peers
CEO-to-median pay ratio
83.81%
Say-on-pay support, latest vote
Companies that benchmark against AVXL
2 companies name AVXL as a compensation peer

Each company listed discloses AVXL in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named AVXL in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2024

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Christopher Missling$700,000$140,000$0$1,927,600$0$0$16,100$2,783,700
President, Chief Executive Officer and Director
Sandra Boenisch201,46800192,700008,059402,227
Principal Financial Officer and Treasurer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2024 totalFY2023 totalFY2022 totalΔ FY20232024
Christopher Missling$2,783,700
Sandra Boenisch402,227

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2024 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Christopher MisslingDirector2025-04-28A125,000$0$0Derivative, Class A CommonForm 4 ↗
Sandra BoenischPFO & Treasurer2025-04-28A12,50000Derivative, Class A CommonForm 4 ↗
Steffen ThomasDirector2025-06-05D11,349887,955CommonForm 4 ↗
Steffen ThomasDirector2025-06-05D50,00000Derivative, Class A CommonForm 4 ↗
Steffen ThomasDirector2025-06-05A50,000288,000CommonForm 4 ↗
Christopher MisslingDirector2025-08-20A125,00000Derivative, Class A CommonForm 4 ↗
Sandra BoenischPFO & Treasurer2025-08-20A12,50000Derivative, Class A CommonForm 4 ↗
Christopher MisslingDirector2025-09-11A187,5005945,000CommonForm 4 ↗
Christopher MisslingDirector2025-09-11D187,50000Derivative, Class A CommonForm 4 ↗
Christopher MisslingDirector2025-09-11D145,048101,389,560CommonForm 4 ↗
Sandra BoenischPFO & Treasurer2025-10-02A12,50000Derivative, Class A CommonForm 4 ↗
Christopher MisslingDirector2025-10-02A125,00000Derivative, Class A CommonForm 4 ↗
Sandra BoenischPFO & Treasurer2026-01-06A12,50000Derivative, Class A CommonForm 4 ↗
Christopher MisslingDirector2026-01-06A125,00000Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2024

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Sandra BoenischOPTION2024-02-2050,00050,00050,000$192,700
Christopher MisslingOPTION2024-02-20500,000500,000500,0001,927,600
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Sandra Boenisch$0$0$192,7000.0%
Christopher Missling001,927,6000.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2024

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Christopher MisslingRSU375,000$900,000
Sandra BoenischRSU50,000120,000
Sandra BoenischRSU30,00072,000
Sandra BoenischRSU40,00096,000
Christopher MisslingRSU500,0001,200,000
05

Incentive-plan design — the Compensation Discussion & Analysis

We seek to compensate our named executive officers in a manner that is competitive, rewards performance that creates stockholder value, recognizes individual contributions, and encourages long-term value creation.

CEO STI target (% of salary)20%
CEO LTI target (% of salary)
Independent consultant
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20242024-06-1828,406,1114,728,255759,62583.81%Passed
20212021-05-2529,900,3193,212,520826,66788.1%Passed
20182018-04-179,907,1302,958,367237,97477.01%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20242024-06-1883.81%a
20212021-05-2588.1%b
20182018-04-1777.01%c

a. Approved under the standard stated in the filing — “Abstentions and broker non-votes, if any, will not be treated as votes cast and will have no impact on the proposal.”.

b. Approved under the standard stated in the filing — “Abstentions will be counted as votes present and entitled to vote on the proposals considered at the Annual Meeting and, therefore, will have the effect of votes against Proposals 2, 3, 4 and 5.”.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

08

Director compensation — fiscal year 2024

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Jiong MaIndependent · Board Chair · Audit · Nominating/Governance$41,000$0$202,200$0$0$243,200
Claus van der VeldenIndependent · Audit (Chair) · Compensation (Chair) · Nominating/Governance (Chair)41,0000202,20000243,200
Athanasios SkarpelosIndependent25,0000202,20000227,200
Steffen ThomasIndependent · Audit · Compensation · Nominating/Governance25,0000202,20000227,200
Peter DonhauserIndependent · Compensation · Nominating/Governance25,0000202,20000227,200
Christopher MisslingEmployee director00000
09

Board fee structure and ownership guideline

Annual cash retainer$25,000
Annual equity retainer$202,200
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)
Stock ownership guideline
09b

Total cost of the board

ComponentFY2024
Cash retainers and fees$157,000
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$157,000

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Anavex Life Sciences2024Christopher Missling$700,000$0$1,927,600$0$2,783,700

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Christopher MisslingDEF 14A2025-04-250001731122-25-000607Section “Summary Compensation”. As printed: 2,783,700. Filing ↗machine: r1 · c23 · span 229348–229357
2Section 01, Sandra BoenischDEF 14A2025-04-250001731122-25-000607Section “Summary Compensation”. As printed: 402,227. Filing ↗machine: r4 · c23 · span 232496–232503
3Section 03, Sandra Boenisch OPTIONDEF 14A2025-04-250001731122-25-000607Section “EXECUTIVE AND DIRECTOR COMPENSATION &” · grants of plan-based awards table. Filing ↗machine: t30 · r4 · c15 · span 232214–232221
4Section 03, Christopher Missling OPTIONDEF 14A2025-04-250001731122-25-000607Section “EXECUTIVE AND DIRECTOR COMPENSATION &” · grants of plan-based awards table. Filing ↗machine: t30 · r1 · c15 · span 228961–228970
5Section 08, Jiong MaDEF 14A2025-04-250001731122-25-000607Section “Director Compensation”. As printed: 243,200. Filing ↗machine: span 314724–314731
6Section 08, Claus van der VeldenDEF 14A2025-04-250001731122-25-000607Section “Director Compensation”. As printed: 243,200. Filing ↗machine: span 315902–315909
7Section 08, Athanasios SkarpelosDEF 14A2025-04-250001731122-25-000607Section “Director Compensation”. As printed: 227,200. Filing ↗machine: span 317080–317087
8Section 08, Steffen ThomasDEF 14A2025-04-250001731122-25-000607Section “Director Compensation”. As printed: 227,200. Filing ↗machine: span 318241–318248
9Section 08, Peter DonhauserDEF 14A2025-04-250001731122-25-000607Section “Director Compensation”. As printed: 227,200. Filing ↗machine: span 319414–319421
10Section 08, Christopher MisslingDEF 14A2025-04-250001731122-25-000607Section “Director Compensation”. As printed: 0. Filing ↗
11Section 02, Christopher Missling 2025-04-28Form 42025-04-300001731122-25-000654Insider equity transaction reported since the proxy statement. Filing ↗
12Section 02, Sandra Boenisch 2025-04-28Form 42025-04-300001731122-25-000655Insider equity transaction reported since the proxy statement. Filing ↗
13Section 02, Steffen Thomas 2025-06-05Form 42025-06-090001731122-25-000837Insider equity transaction reported since the proxy statement. Filing ↗
14Section 02, Steffen Thomas 2025-06-05Form 42025-06-090001731122-25-000837Insider equity transaction reported since the proxy statement. Filing ↗
15Section 02, Steffen Thomas 2025-06-05Form 42025-06-090001731122-25-000837Insider equity transaction reported since the proxy statement. Filing ↗
16Section 02, Christopher Missling 2025-08-20Form 42025-08-220001731122-25-001167Insider equity transaction reported since the proxy statement. Filing ↗
17Section 02, Sandra Boenisch 2025-08-20Form 42025-08-220001731122-25-001168Insider equity transaction reported since the proxy statement. Filing ↗
18Section 02, Christopher Missling 2025-09-11Form 42025-09-120001731122-25-001246Insider equity transaction reported since the proxy statement. Filing ↗
19Section 02, Christopher Missling 2025-09-11Form 42025-09-120001731122-25-001246Insider equity transaction reported since the proxy statement. Filing ↗
20Section 02, Christopher Missling 2025-09-11Form 42025-09-120001731122-25-001246Insider equity transaction reported since the proxy statement. Filing ↗
21Section 02, Sandra Boenisch 2025-10-02Form 42025-10-030001731122-25-001355Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, Christopher Missling 2025-10-02Form 42025-10-030001731122-25-001354Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Sandra Boenisch 2026-01-06Form 42026-01-090001731122-26-000035Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, Christopher Missling 2026-01-06Form 42026-01-090001731122-26-000036Insider equity transaction reported since the proxy statement. Filing ↗
25Section 06, 2024 voteForm 8-K2024-06-210001731122-24-001003Item 5.07 · say-on-pay result. As reported: 83.81% (votes for as printed: 28,406,111). Filing ↗
26Section 06, 2021 voteForm 8-K2021-05-280001731122-21-000974Item 5.07 · say-on-pay result. As reported: 88.1%. Filing ↗
27Section 06, 2018 voteForm 8-K2018-04-200001615774-18-002786Item 5.07 · say-on-pay result. As reported: 77.01%. Filing ↗
28Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
29Section 09b board cost (computed)ComputedcomputedCash 157,000 + equity 0 + all other 0 = 157,000, summed across the director compensation table rows.machine: formula: Σ = 157,000
30Anavex Life Sciences (subject), Section 10b CEO totalDEF 14A2025-04-250001731122-25-000607CEO total compensation as printed in Anavex Life Sciences's own proxy. As printed: 2,783,700. Filing ↗machine: r1 · c23 · span 229348–229357